NYSE$TMO

Thermo Fisher Scientific Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Thermo Fisher Scientific reported strong financial performance and share gain in Q2 2024.

Thermo Fisher Scientific reported a revenue of $10.54 billion for the second quarter of 2024. GAAP diluted EPS increased by 15% to $4.04, and adjusted EPS increased by 4% to $5.37. The company is raising its full-year revenue and adjusted EPS guidance.

  • Second quarter revenue was $10.54 billion.
  • Second quarter GAAP diluted earnings per share (EPS) increased 15% to $4.04.
  • Second quarter adjusted EPS increased 4% to $5.37.
  • The company completed its acquisition of Olink, a provider of differentiated next-generation proteomic solutions.

Headline financials

Total Revenue

$10.5B

Previous: $10.7B-1.4%
EPS

$4.04

Previous: $5.15-21.6%
Adjusted Operating Margin

22.3%

No prior period
GAAP Operating Margin

17.3%

No prior period
Capital Expenditures

-$648M

Previous: -$742M+12.7%
Free Cash Flow

$905M

Previous: $620M+46.0%
Net Income

$1.55B

Previous: $1.36B+14.0%
Operating Income

$1.82B

Previous: $1.58B+15.3%
Cash & Equivalents

$7.07B

Previous: $3.13B+125.8%
Total Assets

$98.5B

Previous: $94.1B+4.7%
R&D Expense

$339M

No prior period
Stock-Based Comp

$84M

Previous: $74M+13.5%

Revenue & EPS history

Thermo Fisher · Revenue · Quarterly

$10.5B

Q2 2024-1.4%vs Q2 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Thermo Fisher · $11B total across 4 segments · Q3 2023

  • Lab Products & Biopharma
    $5.73B+2.6%
  • Life Sciences Solutions
    $2.43B-17.9%
  • Analytical Instruments
    $1.75B+8.2%
  • Specialty Diagnostics
    $1.08B+1.7%

Forward guidance

Thermo Fisher is raising its full-year revenue and adjusted EPS guidance.

Tailwinds

  • Raising revenue guidance to a new range of $42.4 to $43.3 billion versus its previous guidance of $42.3 to $43.3 billion.
  • Raising adjusted EPS guidance to a new range of $21.29 to $22.07 versus its previous guidance of $21.14 to $22.02.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+0.5%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-0.1%

Avg return

30 days after

53%

39 / 73 earnings

Positive

+9.9%

Q2 2012

Best reaction

-7.8%

Q2 2011

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.6%-8.5%-12.7%
Q4 2025-4.6%-6.2%-14.3%
Q3 2025+1.5%+1.0%+5.3%
Q2 2025+3.2%+5.8%+6.3%
Q1 2025-0.7%-3.1%-9.4%
Q4 2024+6.8%+2.2%-6.9%
Q3 2024-4.9%-5.8%-12.5%
Q2 2024+7.7%+9.4%+9.8%
Q1 2024-0.5%+0.4%+1.6%
Q4 2023-2.6%-2.7%+1.6%
Q3 2023-3.9%-5.3%+7.1%
Q2 2023-1.9%-3.9%-5.1%
Q1 2023-1.0%+0.0%-4.8%
Q4 2022+2.9%+1.0%-1.9%
Q3 2022-3.2%-0.1%+7.1%
Q2 2022+2.8%+0.7%-3.1%
Q1 2022+6.2%+5.0%+10.0%
Q4 2021+0.1%-1.2%-7.9%
Q3 2021+1.9%+4.4%+5.0%
Q2 2021+0.7%+0.6%+3.4%
Q1 2021-3.2%-4.2%-3.4%
Q4 2020+1.7%-3.4%-11.5%
Q3 2020+3.6%+3.7%-3.1%
Q2 2020+1.8%+2.6%+6.3%
Q1 2020+0.3%+7.2%+6.5%
Q4 2019-6.2%-2.4%-12.9%
Q3 2019+4.4%+6.7%+9.5%
Q2 2019-1.0%-1.6%-8.3%
Q1 2019+2.1%+3.3%+3.0%
Q4 2018+3.7%+2.8%+11.5%
Q3 2018+3.1%+2.2%+5.2%
Q2 2018+5.7%+4.2%+6.0%
Q1 2018+0.3%-1.3%+0.2%
Q4 2017+3.6%-2.9%-3.8%
Q3 2017+3.1%-1.2%-0.4%
Q2 2017-2.7%-2.6%-1.6%
Q1 2017+5.0%+4.9%+9.2%
Q4 2016+6.7%+5.7%+11.1%
Q3 2016-0.6%-1.4%-2.6%
Q2 2016-0.0%-1.5%-4.1%
Q1 2016-2.0%
Q4 2015-2.8%
Q3 2015-3.6%
Q2 2015+3.0%
Q1 2015-3.6%
Q4 2014+0.7%
Q3 2014-1.7%
Q2 2014+2.0%
Q1 2014-4.1%
Q4 2013+3.0%
Q3 2013+1.3%
Q2 2013+1.9%
Q1 2013-0.6%
Q4 2012+6.2%
Q3 2012+7.1%
Q2 2012+9.9%
Q1 2012+4.1%
Q4 2011-0.1%
Q4 2010-0.1%
Q3 2011-1.5%
Q2 2011-7.8%
Q1 2011-0.2%
Q3 2010-1.7%
Q2 2010+1.0%
Q1 2009-6.2%
Q1 2010+0.2%
Q4 2007-1.3%
Q4 2009-1.3%
Q3 2008-2.8%
Q3 2009-2.8%
Q2 2008+0.5%
Q2 2009+0.5%
Q4 2008+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro